The global obesity epidemic is well established, with increases in obesity prevalence for
most countries since the 1980s. Obesity contributes directly to incident cardiovascular risk …

Obesity is a chronic multisystem disease associated with increased morbidity and mortality.
The increasing prevalence of obesity makes it a major healthcare challenge across both …

Background Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to
reduce the risk of adverse cardiovascular events in patients with diabetes. Whether …

Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

Two billion people worldwide older than 18 years of age, or approximately 30% of the world
population, are overweight or obese. In addition, more than 43 million children under the …

The prevalence of obesity has reached pandemic proportions worldwide and certainly in the
United States. Obesity is a well-established independent risk factor for development of many …

Importance Overweight and obesity have been associated with adverse health effects.
Objective To systematically review evidence on benefits and harms of behavioral and …

Importance More than 35% of men and 40% of women in the United States are obese.
Obesity is associated with health problems such as increased risk for coronary heart …

Objetivo. Estimar os custos atribuíveis a hipertensão arterial, diabetes e obesidade no
Sistema Único de Saúde (SUS) no Brasil em 2018. Métodos. Realizou-se uma estimativa …

Obesity, which is a worldwide epidemic, confers increased risk for multiple serious
conditions including type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular …